Literature DB >> 24570930

Risk stratification for Hepatitis B treatment in the molecular age.

Sanjay R Mehta1, Alexander Kuo2.   

Abstract

Entities:  

Year:  2013        PMID： 24570930      PMCID： PMC3924671          DOI： 10.3978/j.issn.2304-3881.2012.10.15

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  16 in total

Review 1.  Hepatitis B virus infection--natural history and clinical consequences.

Authors:  Don Ganem; Alfred M Prince
Journal:  N Engl J Med       Date:  2004-03-11       Impact factor: 91.245

Review 2.  Selection of chronic hepatitis B therapy with high barrier to resistance.

Authors:  Robert Gish; Ji-Dong Jia; Stephen Locarnini; Fabien Zoulim
Journal:  Lancet Infect Dis       Date:  2012-02-09       Impact factor: 25.071

3.  Genetic variation in IL28B is associated with the development of hepatitis B-related hepatocellular carcinoma.

Authors:  Shan Ren; Junfeng Lu; Xiaofei Du; Yanxiang Huang; Lina Ma; Honglei Huo; Xinyue Chen; Lai Wei
Journal:  Cancer Immunol Immunother       Date:  2012-02-04       Impact factor: 6.968

Review 4.  Hepatitis B virus infection.

Authors:  Jules L Dienstag
Journal:  N Engl J Med       Date:  2008-10-02       Impact factor: 91.245

5.  Chronic hepatitis B: update 2009.

Authors:  Anna S F Lok; Brian J McMahon
Journal:  Hepatology       Date:  2009-09       Impact factor: 17.425

6.  Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers.

Authors:  Hongxing Zhang; Yun Zhai; Zhibin Hu; Chen Wu; Ji Qian; Weihua Jia; Fuchao Ma; Wenfeng Huang; Lixia Yu; Wei Yue; Zhifu Wang; Peiyao Li; Yang Zhang; Renxiang Liang; Zhongliang Wei; Ying Cui; Weimin Xie; Mi Cai; Xinsen Yu; Yunfei Yuan; Xia Xia; Xiumei Zhang; Hao Yang; Wei Qiu; Jingmin Yang; Feng Gong; Minshan Chen; Hongbing Shen; Dongxin Lin; Yi-Xin Zeng; Fuchu He; Gangqiao Zhou
Journal:  Nat Genet       Date:  2010-08-01       Impact factor: 38.330

7.  No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations.

Authors:  Hiromi Sawai; Nao Nishida; Hamdi Mbarek; Koichi Matsuda; Yoriko Mawatari; Megumi Yamaoka; Shuhei Hige; Jong-Hon Kang; Koichi Abe; Satoshi Mochida; Masaaki Watanabe; Masayuki Kurosaki; Yasuhiro Asahina; Namiki Izumi; Masao Honda; Shuichi Kaneko; Eiji Tanaka; Kentaro Matsuura; Yoshito Itoh; Eiji Mita; Masaaki Korenaga; Keisuke Hino; Yoshikazu Murawaki; Yoichi Hiasa; Tatsuya Ide; Kiyoaki Ito; Masaya Sugiyama; Sang Hoon Ahn; Kwang-Hyub Han; Jun Yong Park; Man-Fung Yuen; Yusuke Nakamura; Yasuhito Tanaka; Masashi Mizokami; Katsushi Tokunaga
Journal:  BMC Med Genet       Date:  2012-06-19       Impact factor: 2.103

8.  Association between HLA-DRB1 alleles polymorphism and hepatocellular carcinoma: a meta-analysis.

Authors:  Zhong-Hua Lin; Yong-Ning Xin; Quan-Jiang Dong; Qing Wang; Xiang-Jun Jiang; Shu-Hui Zhan; Ying Sun; Shi-Ying Xuan
Journal:  BMC Gastroenterol       Date:  2010-12-21       Impact factor: 3.067

9.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls.

Authors: 
Journal:  Nature       Date:  2007-06-07       Impact factor: 49.962

10.  Naturally occurring precore/core region mutations of hepatitis B virus genotype C related to hepatocellular carcinoma.

Authors:  Dong-Won Kim; Seoung-Ae Lee; Eung-Soo Hwang; Yoon-Hoh Kook; Bum-Joon Kim
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.